Controversies in Anticoagulation and HIT After Cardiac Surgery

Moderator(s)

• 

  Milan Milojevic, MD, PhD, MSCE, FESC

  Senior Scientific Advisor
  Dedinje Cardiovascular Institute Belgrade
  Dedinje Cardiovascular Institute, University of Belgrade
• 

  Ahmet Kilic, MD (he/him/his)

  The Johns Hopkins Hospital
  Baltimore, Maryland, United States

Presentations:

• 8:00am – 8:05am PT

  Case Presentation with Audience Polling
  

  Invited Speaker: Sameer Hirji, MD MPH – Brigham and Women's Hospital
• 8:05am – 8:13am PT

  Landscape of HIT After Cardiac Surgery—Incidence and Outcomes
  

  Invited Speaker: Irsa Hasan, MD – University of Pittsburgh Medical Center
• 8:13am – 8:21am PT

  Diagnosis of HIT After Cardiac Surgery—How Good is the 4T Score?
  

  Invited Speaker: Subhasis Chatterjee, MD – Baylor College of Medicine
• 8:21am – 8:31am PT

  Venous Thromboembolism After Coronary Artery Bypass Increases Healthcare Costs: A Propensity Score Matched Analysis
  

  Presenting Author: Alex M. Wisniewski, MD, MSc – University of Virginia
• 8:31am – 8:39am PT

  When Should You Switch From Heparin, and What Is the Best Alternative?
  

  Invited Speaker: Natalie Roy, MD – Boston Children's Hospital
• 8:39am – 8:47am PT

  Your Patient with HIT Needs Cardiac Surgery. Now What?
  

  Invited Speaker: Dave C. Fitzgerald, DHA,MPH,CCP – Medical University of South Carolina
• 8:47am – 8:57am PT

  Interim Data Analysis-—Heparin vs. Bivalirudin and ECMO Oxygenator Performance
  

  Presenting Author: Deep P. Vakil, MD (he/him/his) – Memorial Healthcare System
• 8:57am – 9:03am PT

  Debate: Heparin Is the Anticoagulant of Choice in the CTICU
  

  Invited Speaker: Osamudiamen Obanor, MD (he/him/his) – University of Texas Health Sciences- Houston
• 9:03am – 9:09am PT

  Debate: Bivalirudin is the Anticoagulant of Choice in the CTICU
  

  Invited Speaker: Glenn Whitman, MD (he/him/his) – Johns Hopkins Hospital
• 9:09am – 9:15am PT

  Rebuttals
• 9:15am – 9:30am PT

  Moderated Panel Discussion